InvestSMART

Roivant Sciences Ltd (NASDAQ: ROIV) - Share Price

Current share price for ROIV : $39.770 0.21 (0.53%)+

Currency: USD ($)

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

ROIV General Information +

NASDAQ Code ROIV
Industry/Sector Biotechnology
Market Cap ($M) 28,726
ROIV Share Price $39.770
Day High $40.700
Day Low $39.720
Last Close $39.980
ROIV Share Price Movement $0.21 ( 0.53% )
Prices as at 3:26, 19 Sep 2026
+Security prices are at best end-of-day and are indicative only.

ROIV Financial Summary

Operating Revenue Per Share Price to Operating revenue Price to free cash flow Earnings Yield PE Ratio Dividend Yield Forward Dividend Yield Forward Earnings Yield
$0.11 $365.55 ($34.10) 50.87% 1.97 n/a n/a -3.7

ROIV Calendar of Events

Created Date Changed Date Event
30 July 2026 30 July 2026 Company Meeting

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.